☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Hepion
Hepion Pharmaceuticals Begins Wind-Down Activities in ASCEND-NASH P-IIb Study
April 22, 2024
Hepion Collaborates with HepQuant for P-IIb Study of Rencofilstat (CRV431) in NASH
May 4, 2022
PharmaShots Weekly Snapshots (July 12 - 16, 2021)
July 16, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.